以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。

数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15

Hims & Hers

37 atoms · 跨 6 天 · 首见 2026-05-11 · 最近 2026-06-16

三色: 🟦 fact 27 · 🟥 take 10 · stance ▲20/▼2/◆9

叙事状态: 🍂 fading (退潮) · 💤 沉寂 · 策展近14d 0 atom

状态只算低频策展源 (群/卖方); X firehose 仅作背景音量

来源: X 37

时态: fresh:31 · aging:4 · stale:2

标签: 好数字:27 · 好观点:10 · 好信源:4 · 好思考:2

🟨 AI 综合 · junior analyst 概览

展开 AI 综合 (灰色 · 非市场结论 · 点击数字溯源到原 atom)

model: deepseek-chat · 2026-07-12 · 默认折叠

Hims & Hers 全年营收指引达 $2.8B-$3.0B ¹，Q1 收入同比增 4% 至 $6.08 亿，用户近 260 万 ¹ ¹。公司正快速推进 GLP-1 业务：引入 Wegovy 六周内已交付超 12.5 万批 ¹，减肥专科月新增订阅数超 10 万 ¹，并在加拿大首发国际 GLP-1 产品线，个性化套餐起价 CAD$149/月 ¹ ¹。Canaccord 维持买入评级并上调目标价至 $32 ¹ ¹，该行认为公司垂直整合肽类供应链是关键优势，并受益于预防健康的结构性转型 ¹ ¹。分析师预计 Novo Nordisk 合作与订阅势头将驱动下半年增长加速 ¹，但需留意近期利润率承压——管理层预期未来几季毛利率将再压缩数百基点 ¹ ¹。

🟦 客观事实 (facts) (27)

<a id="atom-92757b4f19af3e17"></a>🟦 2026-05-11 X·@AIStockSavvy ⭐ · full-year 2026 revenue guidance · 业绩指引
Full-year 2026 revenue guidance: $2.8B-$3.0B
tags: 好数字·好信源 · → daily
value: qty=$2.8B-$3.0B · date=FY2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-0a1ca0ba15a735c7"></a>🟦 2026-05-11 X·@AIStockSavvy ⭐ · Wegovy shipments within six weeks · 出货量
within six weeks of introducing direct access to Novo Nordisk's GLP-1 products... we have fulfilled more than 125,000 shipments for Wegovy products.
tags: 好数字·好信源 · → daily
value: qty=125,000 · date=2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-cd850888da436d2c"></a>🟦 2026-05-11 X·@AIStockSavvy ⭐ · new subscribers per month in weight loss specialty · 业绩指引
we are on track to add north of 100,000 new subscribers per month within our weight loss specialty.
tags: 好数字·好信源 · → daily
value: qty=100,000 · date=2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-564922312bddddf2"></a>🟦 2026-05-12 X·@AIStockSavvy · future gross margin compression · 毛利率/业绩指引
management expecting another couple hundred basis points of compression over the coming quarters as weight loss, labs, and international scale within the mix.
tags: 好数字·好观点 · → daily
value: qty=another couple hundred basis points · date=over the coming quarters
<a id="atom-6e4360ae470d3c75"></a>🟦 2026-05-21 X·@AIStockSavvy · 国际GLP-1首扩地区 · 产品发布/国际扩张
公司在加拿大首次拓展GLP-1产品线
tags: 好数字 · → daily
value: qty=加拿大 · date=
<a id="atom-879e3628996fc94a"></a>🟦 2026-05-21 X·@AIStockSavvy · 个性化治疗套餐起价 · 定价策略
个性化治疗套餐起价CAD$149/月
tags: 好数字 · → daily
value: qty=CAD$149/月 · date=
<a id="atom-c01da1f6d20a4208"></a>🟦 2026-05-11 X·@AIStockSavvy · Q1 2026 revenue · 营收
Revenue grew 4% year-over-year to $608 million.
tags: 好数字 · → daily
value: qty=$608M · date=2026-Q1
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-1d0a4ff8802d9a42"></a>🟦 2026-05-11 X·@AIStockSavvy · subscribers count · 出货量
Subscribers: nearly 2.6M
tags: 好数字 · → daily
value: qty=2.6M · date=Q1 2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-c19bb6a28d897924"></a>🟦 2026-05-11 X·@AIStockSavvy · operating cash flow · 现金流
operating cash flow: $89M
tags: 好数字 · → daily
value: qty=$89M · date=Q1 2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-d9b0e1a9b400ae64"></a>🟦 2026-05-11 X·@AIStockSavvy · free cash flow · 现金流
free cash flow: $53M
tags: 好数字 · → daily
value: qty=$53M · date=Q1 2026
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-96fb62bb9cbc1cd9"></a>🟦 2026-05-11 X·@AIStockSavvy · international revenue Q1 2026 · 营收
international revenue increased nearly tenfold from the first quarter to $78 million.
tags: 好数字 · → daily
value: qty=$78M · date=2026-Q1
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-c29af8659ff54d36"></a>🟦 2026-05-11 X·@AIStockSavvy · marketing as percentage of revenue Q1 2026 · 盈利能力
Marketing as a percentage of revenue improved three points year-over-year and quarter-over-quarter to 36% in Q1.
tags: 好数字 · → daily
value: qty=36% · date=2026-Q1
[图: Hims & Hers 2026年第一季度业绩电话会议亮点总结表格 — Q1 2026 revenue: $608M; Full-year 2026 revenue guidance: $2.8B-$3.0B; Subscribers: nearly 2.6M; Operating cash flow: $89M; Free cash flow: $
📷 原图
<a id="atom-77c97d6add346ae0"></a>🟦 2026-05-21 X·@AIStockSavvy · 推出加拿大版司美格鲁肽 · 产品发布/国际扩张
Hims & Hers 在加拿大推出司美格鲁肽仿制药
tags: 好信源 · → daily
value: qty= · date=
<a id="atom-560f1ce20722839d"></a>🟦 2026-05-18 X·@AIStockSavvy · 可转换债券发行金额 · 融资
$HIMS Hims & Hers announces $300 million convertible notes offering
tags: 好数字 · → daily
value: qty=$300 million
<a id="atom-5b9880deacb89488"></a>🟦 2026-05-12 X·@AIStockSavvy · Q1 2026 revenue · 财报
Hims reported mixed Q1 results, with both revenue and adjusted EBITDA coming in modestly below expectations.
tags: 好数字 · → daily
value: qty=below expectations · date=Q1 2026
<a id="atom-f42f96d51f2f39af"></a>🟦 2026-05-12 X·@AIStockSavvy · Q1 2026 adjusted EBITDA · 盈利能力
Hims reported mixed Q1 results, with both revenue and adjusted EBITDA coming in modestly below expectations.
tags: 好数字 · → daily
value: qty=below expectations · date=Q1 2026
<a id="atom-4a4737c7bb7aa08e"></a>🟦 2026-05-12 X·@AIStockSavvy · Q1 2026 gross margin · 毛利率
GMs compressed to 65% on a reported basis, or 70% adjusted for one-time charges related to the wind-down of compounded GLP-1 supply chain investments
tags: 好数字 · → daily
value: qty=65% · date=Q1 2026
<a id="atom-a10fc34e73c5d75b"></a>🟦 2026-05-12 X·@AIStockSavvy · adjusted Q1 2026 gross margin · 毛利率
GMs compressed to 65% on a reported basis, or 70% adjusted for one-time charges related to the wind-down of compounded GLP-1 supply chain investments
tags: 好数字 · → daily
value: qty=70% · date=Q1 2026
<a id="atom-e953ce21de8fd5b1"></a>🟦 2026-05-12 X·@AIStockSavvy · Wegovy shipments within first six weeks of launch · 出货量/合作客户
the Novo partnership is off to a strong start, with 125K+ Wegovy shipments fulfilled within six weeks of launch
tags: 好数字 · → daily
value: qty=125K+ · date=first six weeks of launch
<a id="atom-6913b02feb137543"></a>🟦 2026-05-12 X·@AIStockSavvy · weight loss subscriber adds per month · 订单需求
weight loss subscriber adds tracking north of 100K/month at what management characterized as near-record levels
tags: 好数字 · → daily
value: qty=north of 100K/month
<a id="atom-1c852f5c87b6d1b2"></a>🟦 2026-05-12 X·@AIStockSavvy · percentage of new subscribers downloading the app · 合作客户
nearly 90% of new subscribers downloading the app
tags: 好数字 · → daily
value: qty=nearly 90%
<a id="atom-e81aacb1a89add48"></a>🟦 2026-05-12 X·@AIStockSavvy · FY26 revenue outlook raised · 业绩指引
Hims raised its FY26 revenue outlook by ~3.5% at the midpoint
tags: 好数字 · → daily
value: qty=~3.5% at the midpoint · date=FY26
<a id="atom-c134fa5e8673192e"></a>🟦 2026-05-12 X·@AIStockSavvy · revenue from branded Novo products recognition basis · 营收
Management confirmed that revenue from branded Novo products fulfilled through Hims' pharmacies is recognized on a gross basis
tags: 好数字 · → daily
value: qty=gross basis
<a id="atom-91c036d935e7e086"></a>🟦 2026-05-12 X·@AIStockSavvy · contribution dollar economics between branded and compounded GLP-1 drugs · 盈利能力
contribution dollar economics between branded and compounded being roughly comparable
tags: 好数字 · → daily
value: direction=comparable
<a id="atom-1007863ee786ed6c"></a>🟦 2026-05-12 X·@AIStockSavvy · early signs of traction in newer specialties · 产品发布
the company is also seeing early signs of traction across newer specialties, including testosterone, menopause, and labs, and the emerging peptide opportunity is beginning to take shape as the regulatory path becomes clearer into July
tags: 好观点 · → daily
value: direction=bullish
<a id="atom-5fd55bd549720380"></a>🟦 2026-05-12 X·@AIStockSavvy · majority of FY26 guide increase reflects healthy demand patterns · 订单需求
the majority of the guide increase reflects healthy demand patterns rather than revenue recognition adjustments alone
tags: 好观点 · → daily
value: direction=bullish
<a id="atom-06c17d9e9cf9fda9"></a>🟦 2026-05-12 X·@AIStockSavvy · leaning further into investment across technology, verticalization, and international expansion · 资本开支
the company is leaning further into investment across technology, verticalization, and international expansion, which pressured the profitability outlook
tags: 好观点 · → daily
value: direction=neutral

🟥 多头 takes (bullish) (8)

<a id="atom-9e217b9ba6a693c1"></a>🟥 2026-06-16 X·@himshouse · implied share of peptides market broader case · 营收预测/市场份额
$HIMS's implied share of the peptides market would be ~$440M in the broader case
tags: 好数字·好思考 · → daily
value: qty=$440M · date=2027
<a id="atom-7e5ab4478f02371a"></a>🟥 2026-06-03 X·@AIStockSavvy [老旧] · Canaccord maintains PT · 评级目标价
maintains 𝐏𝐓 𝐚𝐭 $𝟑𝟐
tags: 好数字 · → daily
value: qty=$32
📷 原图
<a id="atom-355577ef02c3e3aa"></a>🟥 2026-05-12 X·@AIStockSavvy [老化中] · Canaccord price target · 评级目标价
Canaccord maintains Buy, raises PT to $32
tags: 好数字 · → daily
value: qty=$32
📷 原图
<a id="atom-4185105db0f9e786"></a>🟥 2026-06-03 X·@AIStockSavvy [老旧] · Canaccord reiterates Buy rating · 评级目标价
Canaccord reiterates 𝐁𝐮𝐲 on 𝐇𝐢𝐦𝐬 & 𝐇𝐞𝐫𝐬, maintains 𝐏𝐓 𝐚𝐭 $𝟑𝟐
tags: 好观点 · → daily
📷 原图
<a id="atom-ed51e8908bcdfbb0"></a>🟥 2026-06-03 X·@AIStockSavvy · analyst sees well-positioned for structural shift towards preventive health · 竞争格局
Analyst sees Hims well-positioned for a structural shift towards preventive health
tags: 好观点 · → daily
📷 原图
<a id="atom-5bd02b710182bb90"></a>🟥 2026-06-03 X·@AIStockSavvy · vertical integration in peptides is key advantage · 竞争格局
with its vertical integration in peptides a key advantage
tags: 好观点 · → daily
📷 原图
<a id="atom-9c254413c0a58326"></a>🟥 2026-05-12 X·@AIStockSavvy [老化中] · Canaccord analyst rating · 评级目标价
Canaccord maintains Buy, raises PT to $32
tags: 好观点 · → daily
value: direction=Buy
📷 原图
<a id="atom-e19248ffe448d190"></a>🟥 2026-05-12 X·@AIStockSavvy [老化中] · Canaccord analyst sees Novo partnership and subscriber momentum driving 2H growth acceleration · 订单需求/合作客户
Analyst sees $NVO Novo partnership and strong subscriber momentum driving 2H growth acceleration despite near-term margin pressure.
tags: 好观点 · → daily
value: direction=bullish
📷 原图

🟥 空头 takes (bearish) (1)

<a id="atom-bce93c85f5ad43e0"></a>🟥 2026-05-12 X·@AIStockSavvy [老化中] · near-term margin pressure · 盈利能力/毛利率
despite near-term margin pressure
tags: 好观点 · → daily
value: direction=bearish
📷 原图

🟥 中性 takes (neutral) (1)

<a id="atom-b55bf7ac189ce12b"></a>🟥 2026-06-16 X·@himshouse · implied share of peptides market narrower case · 营收预测/市场份额
$HIMS's implied share of the peptides market would be ... ~$220M in the narrower case
tags: 好数字·好思考 · → daily
value: qty=$220M · date=2027

⏱ 时间轴 (近 20)

🟥 2026-06-16 · forecast · implied share of peptides market broader case · → daily
🟥 2026-06-16 · forecast · implied share of peptides market narrower case · → daily
🟥 2026-06-03 · position · Canaccord reiterates Buy rating · → daily
🟥 2026-06-03 · position · Canaccord maintains PT · → daily
🟥 2026-06-03 · narrative · analyst sees well-positioned for structural shift towards pr · → daily
🟥 2026-06-03 · narrative · vertical integration in peptides is key advantage · → daily
🟦 2026-05-21 · fact · 推出加拿大版司美格鲁肽 · → daily
🟦 2026-05-21 · fact · 国际GLP-1首扩地区 · → daily
🟦 2026-05-21 · fact · 个性化治疗套餐起价 · → daily
🟦 2026-05-18 · fact · 可转换债券发行金额 · → daily
🟦 2026-05-12 · fact · Q1 2026 revenue · → daily
🟦 2026-05-12 · fact · Q1 2026 adjusted EBITDA · → daily
🟦 2026-05-12 · fact · Q1 2026 gross margin · → daily
🟦 2026-05-12 · fact · adjusted Q1 2026 gross margin · → daily
🟦 2026-05-12 · fact · future gross margin compression · → daily
🟦 2026-05-12 · fact · Wegovy shipments within first six weeks of launch · → daily
🟦 2026-05-12 · fact · weight loss subscriber adds per month · → daily
🟦 2026-05-12 · fact · percentage of new subscribers downloading the app · → daily
🟦 2026-05-12 · fact · FY26 revenue outlook raised · → daily
🟦 2026-05-12 · fact · revenue from branded Novo products recognition basis · → daily

← 实体目录 · 系统日志